Borna disease virus matrix protein is an integral component of the viral ribonucleoprotein complex that does not interfere with polymerase activity

Journal of Virology

Volumn 81, Issue 2, 2007, Pages 743-749

  Chase, Geoffrey ^a   Mayer, Daniel ^a   Hildebrand, Antonia ^a   Frank, Ronald ^b   Hayashi, Yohei ^c   Tomonaga, Keizo ^c   Schwemmle, Martin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX PROTEIN; NUCLEOCAPSID PROTEIN; PHOSPHOPROTEIN; POLYCLONAL ANTIBODY; RIBONUCLEOPROTEIN; RNA POLYMERASE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BORNA DISEASE VIRUS; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IN SITU HYBRIDIZATION; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; VIRUS GENOME;

ANIMALS; BORNA DISEASE VIRUS; CELL LINE; CERCOPITHECUS AETHIOPS; DNA-DIRECTED RNA POLYMERASES; HUMANS; PHOSPHOPROTEINS; RIBONUCLEOPROTEINS; SUBCELLULAR FRACTIONS; VERO CELLS; VIRAL MATRIX PROTEINS; VIRAL PROTEINS;

BORNA DISEASE VIRUS; ORYCTOLAGUS CUNICULUS; RNA VIRUSES;

EID: 33846101579     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01351-06     Document Type: Article

References (39)

1. Billich, C., C. Sauder, R. Frank, S. Herzog, K. Bechter, K. Takahashi, H. Peters, P. Staeheli, and M. Schwemmle. 2002. High-avidity human serum antibodies recognizing linear epitopes of Borna disease virus proteins. Biol. Psychiatry 51:979-987.
2. Briese, T., J. C. de la Torre, A. Lewis, H. Ludwig, and W. I. Lipkin. 1992. Borna disease virus, a negative-strand RNA virus, transcribes in the nucleus of infected cells. Proc. Natl. Acad. Sci. USA 89:11486-11489.
3. Briese, T., A. Schneemann, A. J. Lewis, Y.-S. Park, S. Kim, H. Ludwig, and W. I. Lipkin. 1994. Genomic organization of Borna disease virus. Proc. Natl. Acad. Sci. USA 91:4362-4366.
4. Buchholz, U. J., S. Finke, and K. K. Conzelmann. 1999. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J. Virol. 73:251-259.
5. Capone, J., and H. P. Ghosh. 1984. Association of the nucleocapsid protein N of vesicular stomatitis virus with phospholipid vesicles containing the matrix protein M. Can. J. Biochem. Cell Biol. 62:1174-1180.
6. Clinton, G. M., S. P. Little, F. S. Hagen, and A. S. Huang. 1978. The matrix (M) protein of vesicular stomatitis virus regulates transcription. Cell 15: 1455-1462.
7. Cornu, T. I., and J. C. de la Torre. 2001. RING finger Z protein of lymphocytic choriomeningitis virus (LCMV) inhibits transcription and RNA replication of an LCMV S-segment minigenome. J. Virol. 75:9415-9426.
8. Coronel, E. C., T. Takimoto, K. G. Murti, N. Varich, and A. Portner. 2001. Nucleocapsid incorporation into parainfluenza virus is regulated by specific interaction with matrix protein. J. Virol. 75:1117-1123.
9. Dubovi, E. J., and R. R. Wagner. 1977. Spatial relationships of the proteins of vesicular stomatitis virus: induction of reversible oligomers by cleavable protein cross-linkers and oxidation. J. Virol. 22:500-509.
10. Finke, S., and K. K. Conzelmann. 2003. Dissociation of rabies virus matrix protein functions in regulation of viral RNA synthesis and virus assembly. J. Virol. 77:12074-12082.
11. Finke, S., R. Mueller-Waldeck, and K. K. Conzelmann. 2003. Rabies virus matrix protein regulates the balance of virus transcription and replication. J. Gen. Virol. 84:1613-1621.
12. Frank, R. 1992. Spot-synthesis: an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support. Tetrahedron 48:9217-9232.
13. Ghildyal, R., C. Baulch-Brown, J. Mills, and J. Meanger. 2003. The matrix protein of human respiratory syncytial virus localises to the nucleus of infected cells and inhibits transcription. Arch. Virol. 148:1419-1429.
14. Gomis-Ruth, F. X., A. Dessen, J. Timmins, A. Bracher, L. Kolesnikowa, S. Becker, H. D. Klenk, and W. Weissenhorn. 2003. The matrix protein VP40 from Ebola virus octamerizes into pore-like structures with specific RNA binding properties. Structure 11:423-433.
15. Gonzalez-Dunia, D., R. Volmer, D. Mayer, and M. Schwemmle. 2005. Borna disease virus interference with neuronal plasticity. Virus Res. 111:224-234.
16. Haas, B., H. Becht, and R. Rott. 1986. Purification and properties of an intranuclear virus-specific antigen from tissue infected with Borna disease virus. J. Gen. Virol. 67:235-241.
17. Hornig, M., T. Briese, and W. I. Lipkin. 2003. Borna disease virus. J. Neurovirol. 9:259-273.
18. Kraus, I., E. Bogner, H. Lilie, M. Eickmann, and W. Garten. 2005. Oligomerization and assembly of the matrix protein of Borna disease virus. FEBS Lett. 579:2686-2692.
19. Kraus, I., M. Eickmann, S. Kiermayer, H. Scheffczik, M. Fluess, J. A. Richt, and W. Garten. 2001. Open reading frame III of Borna disease virus encodes a nonglycosylated matrix protein. J. Virol. 75:12098-12104.
20. Laemmli, U. K., and M. Favre. 1973. Maturation of the head of bacteriophage T4. J. Mol. Biol. 80:575-581.
21. Lenard, J. 1996. Negative-strand virus M and retrovirus MA proteins: all in a family? Virology 216:289-298.
22. Markwell, M. A., and C. F. Fox. 1980. Protein-protein interactions within paramyxoviruses identified by native disulfide bonding or reversible chemical cross-linking. J. Virol. 33:152-166.
23. Mayer, D., S. Baginsky, and M. Schwemmle. 2005. Isolation of viral ribonucleoprotein complexes from infected cells by tandem affinity purification. Proteomics 5:4483-4487.
24. Ogino, T., M. Iwama, Y. Ohsawa, and K. Mizumoto. 2003. Interaction of cellular tubulin with Sendai virus M protein regulates transcription of viral genome. Biochem. Biophys. Res. Commun. 311:283-293.
25. Pauli, G., and H. Ludwig. 1985. Increase of virus yields and releases of Borna disease virus from persistently infected cells. Virus Res. 2:29-33.
26. Reuter, T., B. Weissbrich, S. Schneider-Schaulies, and J. Schneider-Schaulies. 2006. RNA interference with measles virus N, P, and L mRNAs efficiently prevents and with matrix protein mRNA enhances viral transcription. J. Virol. 80:5951-5957.
27. Rodriguez, L., I. Cuesta, A. Asenjo, and N. Villanueva. 2004. Human respiratory syncytial virus matrix protein is an RNA-binding protein: binding properties, location and identity of the RNA contact residues. J. Gen. Virol. 85:709-719.
28. Schneider, U. 2005. Novel insights into the regulation of the viral polymerase complex of neurotropic Borna disease virus. Virus Res. 111:148-160.
29. Schneider, U., K. Blechschmidt, M. Schwemmle, and P. Staeheli. 2004. Overlap of interaction domains indicates a central role of the P protein in assembly and regulation of the Borna disease virus polymerase complex. J. Biol. Chem. 279:55290-55296.
30. Schneider, U., M. Naegele, P. Staeheli, and M. Schwemmle. 2003. Active Borna disease virus polymerase complex requires a distinct nucleoprotein-to-phosphoprotein ratio but no viral X protein. J. Virol. 77:11781-11789.
31. Schneider, U., M. Schwemmle, and P. Staeheli. 2005. Genome trimming: a unique strategy for replication control employed by Borna disease virus. Proc. Natl. Acad. Sci. USA 102:3441-3446.
32. Schwardt, M., D. Mayer, R. Frank, U. Schneider, M. Eickmann, O. Planz, T. Wolff, and M. Schwemmle. 2005. The negative regulator of Borna disease virus polymerase is a non-structural protein. J. Gen. Virol. 86:3163-3169.
33. Schwemmle, M., M. Salvatore, L. Shi, J. Richt, C. Lee, and W. Lipkin. 1998. Interactions of the Borna disease virus P, N, and X proteins and their functional implications. J. Biol. Chem. 273:9007-9012.
34. Staeheli, P., C. Sauder, J. Hausmann, F. Ehrensperger, and M. Schwemmle. 2000. Epidemiology of Borna disease virus. J. Gen. Virol. 81:2123-2135.
35. Suryanarayana, K., K. Baczko, V. ter Meulen, and R. R. Wagner. 1994. Transcription inhibition and other properties of matrix proteins expressed by M genes cloned from measles viruses and diseased human brain tissue. J. Virol. 68:1532-1543.
36. Wakefleld, L., and G. G. Brownlee. 1989. RNA-binding properties of influenza A virus matrix protein M1. Nucleic Acids Res. 17:8569-8580.
37. Watanabe, K., H. Handa, K. Mizumoto, and K. Nagata. 1996. Mechanism for inhibition of influenza virus RNA polymerase activity by matrix protein. J. Virol. 70:241-247.
38. Ye, Z., T. Liu, D. P. Offringa, J. McInnis, and R. A. Levandowski. 1999. Association of influenza virus matrix protein with ribonucleoproteins. J. Virol. 73:7467-7473.
39. Zvonarjev, A, Y., and Y. Z. Ghendon. 1980. Influence of membrane (M) protein on influenza A virus virion transcriptase activity in vitro and its susceptibility to rimantadine. J. Virol. 33:583-586.